NBDF: Proud to See Our Own Teri F Willey Representing the Foundation in the Funding Rare Disease Research Webinar
National Bleeding Disorders Foundation (NBDF) reposted from Fondation Ipsen on LinkedIn:
”NBDF is proud to see our own Teri F Willey representing the foundation in the upcoming Funding Rare Disease Research: Collaboration to Accelerate Treatment Innovation webinar, hosted by Science Magazine
This important discussion will explore how collaboration among nonprofits, investors, industry, and policymakers can accelerate innovation and expand access to treatments for rare diseases.”
Fondation Ipsen shared on LinkedIn:
”Our President, Professor James Levine joined an outstanding panel of experts – including Teri F Willey, Paola Pozzi, Adora Ndu – to explore how diverse funding models can accelerate progress for rare diseases.
We were proud to sponsor the webinar “Funding Rare Disease Research: Collaboration to Accelerate Treatment Innovation” in partnership with Science Magazine.
Sign up to watch the full webinar on September 18th.”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
-
Sep 6, 2026, 04:38M. Ibrahim Siddique: Does Routine Triple Therapy Pay Off After Anterior STEMI?
-
Sep 6, 2026, 04:29Sandra Revill Tremulis: The Lp(a)HORIZON Topline Results Raise Important Questions Beyond Simply ‘Does Lowering Lp(a) Work?’
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment